George Krashias

Nicosia, 2371, Cyprus

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Epstein-Barr Virus and Multiple Sclerosis: Mechanistic Insights into Virus-Driven Autoimmunity.

Epstein-Barr Virus and Multiple Sclerosis: Mechanistic Insights into Virus-Driven Autoimmunity.

Journal: Microorganisms
Published: June 25, 2026

The Role of TLR3 rs3775291 Variant in West Nile Virus Infection: A Case-Control Study.

The Role of TLR3 rs3775291 Variant in West Nile Virus Infection: A Case-Control Study.

Journal: Microorganisms
Published: October 03, 2025

Prevalence of Viral and Bacterial Co-Infections in SARS-CoV-2-Positive Individuals in Cyprus 2020-2022.

Prevalence of Viral and Bacterial Co-Infections in SARS-CoV-2-Positive Individuals in Cyprus 2020-2022.

Journal: Biomedicines
Published: March 28, 2025

Serum Reactive Antibodies against the N-Methyl-D-Aspartate Receptor NR2 Subunit-Could They Act as Potential Biomarkers?

Serum Reactive Antibodies against the N-Methyl-D-Aspartate Receptor NR2 Subunit-Could They Act as Potential Biomarkers?

Journal: International journal of molecular sciences
Published: September 04, 2023

A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis.

A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis.

Journal: International journal of molecular sciences
Published: June 06, 2023

A Preclinical Investigation on the Role of IgG Antibodies against Coagulant Components in Multiple Sclerosis.

A Preclinical Investigation on the Role of IgG Antibodies against Coagulant Components in Multiple Sclerosis.

Journal: Biomedicines
Published: February 17, 2023

SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis receiving different disease-modifying treatments.

SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis receiving different disease-modifying treatments.

Journal: Frontiers in neurology
Published: November 08, 2022

Genetic Markers for Thrombophilia and Cardiovascular Disease Associated with Multiple Sclerosis.

Genetic Markers for Thrombophilia and Cardiovascular Disease Associated with Multiple Sclerosis.

Journal: Biomedicines
Published: September 28, 2022

SARS CoV- 2 vaccination induces antibodies against cardiolipin.

SARS CoV- 2 vaccination induces antibodies against cardiolipin.

Journal: BMC research notes
Published: June 23, 2022

Evaluation of S1RBD-Specific IgG Antibody Responses following COVID-19 Vaccination in Healthcare Professionals in Cyprus: A Comparative Look between the Vaccines of Pfizer-BioNTech and AstraZeneca.

Evaluation of S1RBD-Specific IgG Antibody Responses following COVID-19 Vaccination in Healthcare Professionals in Cyprus: A Comparative Look between the Vaccines of Pfizer-BioNTech and AstraZeneca.

Journal: Microorganisms
Published: April 06, 2022

Antibodies to blood coagulation components are implicated in patients with multiple sclerosis.

Antibodies to blood coagulation components are implicated in patients with multiple sclerosis.

Journal: Multiple sclerosis and related disorders
Published: January 13, 2022

Characterization of IgG Antibody Response against SARS-CoV-2 (COVID-19) in the Cypriot Population.

Characterization of IgG Antibody Response against SARS-CoV-2 (COVID-19) in the Cypriot Population.

Journal: Microorganisms
Published: October 11, 2021
Showing 1-12 of 20

Last Updated: 09/26/2026